Bank of New York Mellon’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bank of New York Mellon’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,303	Closed	-$1.67M	–	4338
2026 Q1	$1.67M	Buy	8,303 +615	+8%	+$127K	﹤0.01%	2908
2025 Q4	$1.59M	Buy	7,688 +161	+2%	+$32.2K	﹤0.01%	2975
2025 Q3	$1.35M	Buy	7,527 +227	+3%	+$38.7K	﹤0.01%	3035
2025 Q2	$1.18M	Buy	7,300 +616	+9%	+$98.1K	﹤0.01%	3050
2025 Q1	$1.14M	Sell	6,684 -136	-2%	-$23.6K	﹤0.01%	2993
2024 Q4	$1.13M	Sell	6,820 -2,085	-23%	-$356K	﹤0.01%	3080
2024 Q3	$1.53M	Buy	+8,905	New	+$1.47M	﹤0.01%	2893
2023 Q4	–	Sell	-12,118	Closed	-$1.77M	–	4324
2023 Q3	$1.77M	Buy	12,118 +301	+3%	+$45.9K	﹤0.01%	2876
2023 Q2	$1.81M	Buy	+11,817	New	+$1.84M	﹤0.01%	2900
2020 Q1	–	Sell	-1,517	Closed	-$226K	–	4123
2019 Q4	$226K	Buy	+1,517	New	+$208K	﹤0.01%	3884
2019 Q3	–	Sell	-2,347	Closed	-$331K	–	4225
2019 Q2	$331K	Buy	+2,347	New	+$324K	﹤0.01%	3779

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

CAG

Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Bank of New York Mellon's FBT Position: Q2 2026 in Review

Bank of New York Mellon sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 8,303 shares — an estimated $1.67M sold.

Bank of New York Mellon first reported a position in FBT in Q2 2019 and held it in 11 quarters. The position peaked at $1.81M in Q2 2023. 241 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Bank of New York Mellon reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
Bank of New York Mellon sold 8,303 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.67M.
Bank of New York Mellon first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and held it in 11 quarters.
Bank of New York Mellon's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.81M in Q2 2023.
241 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.